A significant subset of AML with an NPM1 mutation shows an “APL-like” immune profile (CD15-/CD34-/HLA-DR-/strong myeloperoxidase) [15,75,76,77,78]. The gene discussed is MPO; the disease is acute myeloid leukemia.